[go: up one dir, main page]

IL161332A0 - Pacap compositions and methods for tumor imaging and therapy - Google Patents

Pacap compositions and methods for tumor imaging and therapy

Info

Publication number
IL161332A0
IL161332A0 IL16133202A IL16133202A IL161332A0 IL 161332 A0 IL161332 A0 IL 161332A0 IL 16133202 A IL16133202 A IL 16133202A IL 16133202 A IL16133202 A IL 16133202A IL 161332 A0 IL161332 A0 IL 161332A0
Authority
IL
Israel
Prior art keywords
pacap
therapy
compositions
methods
tumor imaging
Prior art date
Application number
IL16133202A
Other languages
English (en)
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jefferson filed Critical Univ Jefferson
Publication of IL161332A0 publication Critical patent/IL161332A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16133202A 2001-10-19 2002-10-21 Pacap compositions and methods for tumor imaging and therapy IL161332A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34451101P 2001-10-19 2001-10-19
PCT/US2002/033904 WO2003033030A1 (en) 2001-10-19 2002-10-21 Pacap compositions and methods for tumor imaging and therapy

Publications (1)

Publication Number Publication Date
IL161332A0 true IL161332A0 (en) 2004-09-27

Family

ID=23350835

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16133202A IL161332A0 (en) 2001-10-19 2002-10-21 Pacap compositions and methods for tumor imaging and therapy

Country Status (9)

Country Link
US (1) US6855308B2 (zh)
EP (1) EP1441773A1 (zh)
JP (1) JP2005514335A (zh)
KR (1) KR20040055784A (zh)
CN (1) CN1571680A (zh)
CA (1) CA2464002C (zh)
IL (1) IL161332A0 (zh)
RU (1) RU2004115104A (zh)
WO (1) WO2003033030A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2472956A1 (en) * 2002-02-14 2003-08-21 Bayer Pharmaceuticals Corporation Formulation strategies in stabilizing peptides in organic solvents and in dried states
EP1778268B1 (en) * 2004-07-21 2016-05-04 Tulane University Health Sciences Center Treatment of renal dysfunction and multiple myeloma using pacap compounds
WO2011013703A1 (ja) * 2009-07-31 2011-02-03 独立行政法人理化学研究所 膵臓内分泌細胞用指示薬、及びその利用
CA2779496A1 (en) 2009-11-02 2011-05-05 The Administrators Of The Tulane Educational Fund Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use
EP2586865B1 (en) * 2010-06-24 2018-03-21 Genomictree, Inc. Recombinant vector for suppressing proliferation of human papillomavirus cell including adenylate cyclase activating polypeptide 1 (pituitary) gene and pharmaceutical composition for treating human papillomavirus
SG11201506407VA (en) * 2013-02-15 2015-09-29 Univ Jefferson Kit for tumor imaging
EP3036008A4 (en) * 2013-08-22 2017-04-05 Robert Doyle Compositions comprising vitamin b12 and intrinsic factor and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107459A (en) * 1991-02-08 2000-08-22 Diatide, Inc. Technetium-99m labeled peptides for diagnostic imaging
US5997844A (en) * 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US6165755A (en) * 1997-01-23 2000-12-26 University Of Victoria Innovation And Development Corporation Chicken neuropeptide gene useful for improved poultry production
US6395255B1 (en) * 1998-06-15 2002-05-28 Thomas Jefferson University Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy

Also Published As

Publication number Publication date
EP1441773A1 (en) 2004-08-04
RU2004115104A (ru) 2005-02-20
CN1571680A (zh) 2005-01-26
CA2464002C (en) 2011-06-28
JP2005514335A (ja) 2005-05-19
CA2464002A1 (en) 2003-04-24
WO2003033030A1 (en) 2003-04-24
KR20040055784A (ko) 2004-06-26
US6855308B2 (en) 2005-02-15
US20030129133A1 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
IL251270A0 (en) Cancer treatment
AU2002360766A8 (en) Methods for cancer imaging
AU6147401A (en) Compositions and methods for the treatment of cancer
IL165950A0 (en) Compositions and method for the diagnosis and treatment of tumor
HUP0400314A3 (en) Pharmaceutical combinations for the treatment of cancer
PL365244A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
IL164896A (en) Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
IL159887A0 (en) Combination therapy for the treatment of cancer
PL368458A1 (en) Improved use of antitumoral compound in cancer therapy
EP1476067A4 (en) COMPOSITIONS AND METHODS FOR CANCER
MXPA03008582A (es) Agentes y metodos para tratamiento de cancer.
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
EP1461047A4 (en) COMPOSITIONS AND METHODS FOR TREATING ANIMALS
IL158206A0 (en) Compositions and methods for the prevention and treatment of human prostate cancer
IL145397A0 (en) Compositions and methods for treatment of cancer
EP1469769A4 (en) NEW COMPOSITIONS AND METHODS AGAINST CANCER
PL368035A1 (en) Compositions and methods for the treatment of cancer
MXPA03007036A (es) Metodo de terapia para cancer.
IL161332A0 (en) Pacap compositions and methods for tumor imaging and therapy
EP1469870A4 (en) NEW COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
AU2002332606A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
EP1463511A4 (en) COMBINATORY ANTICANCER THERAPY
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease